28-May-2015 - Sovaldi maker Gilead Sciences has opened a new laboratory and is investing a further $100m (€91m) for API manufacturing at its site in Canada.
News in brief
27-May-2015 - US production of chemicals for the drug industry fell in April according to data released days after renewed calls for permanent tax breaks to help American manufacturers compete globally.
27-May-2015 - Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if it goes on to be approved says Sunshine Biopharma.
26-May-2015 - WR Grace says certification for its excipient plant in Germany will reduce the audit burden faced by drug industry customers.
21-May-2015 - Access to yeast strains modified to produce opiates must be controlled say researchers who warn that stopping criminals using such API manufacturing routes to make narcotics is vital.
19-May-2015 - Symbiosis Pharmaceutical Services has launched a bulk freeze drying offering for APIs and intermediates, citing new contracts as a driver for the investment.
18-May-2015 - Dr Reddy’s has set out to build in the Japanese market days after revealing that higher generic and API sales elsewhere had been pegged back by currency fluctuations.
13-May-2015 - SAFC has announced investments in gene therapy manufacturing sites in Missouri and California.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.